Abstract
Return of previously extinguished fear memories presents a major hurdle in treatment of fear-related disorders. Neuropeptide Y receptors type 2 (Y2R) in the bed nucleus of stria terminalis (BNST) seem to play a crucial role in modulation of remote fear memories. Here, we targeted Cre-channelrhodopsin-2 to defined subregions of BNST or central amygdala (CeA) in floxed Y2R mice (Y2lox/lox) for functional deletion of Y2R. We combined fear training and behavioral studies in vivo with optogenetic-electrophysiological analysis of BNST synaptic network activity ex vivo, in order to identify regional and cellular specificities of Y2R influence. Deletion of Y2R in the ventral section of anterior BNST (BNSTav) did not affect fear acquisition, but increased conditioned fear during recall and extinction learning, and aggravated remote fear return. By contrast, deletion of Y2R in the dorsal section of anterior BNST (BNSTad) or CeA did not influence acquisition, extinction or return of fear memories. Ex vivo optogenetic-electrophysiological analysis revealed Y2R-expressing local GABAergic inhibitory networks in BNST, both within (intraregional) and in-between (inter-regional) BNST subregions. Stimulation of Y2R resulted in a presynaptically mediated reduction of GABAergic responses, which did not differ between intraregional but predominantly affected inter-regional connections from BNSTav to BNSTad. Moreover, deletion of Y2R decreased the excitation/inhibition balance in BNSTav neurons, suggesting a regulatory influence of endogenous NPY via intraregional GABAergic microcircuits. This study reveals Y2R within local GABAergic networks in BNST as key elements in facilitating extinction and reducing return of remote fear memories, suggesting a potential avenue for translational purposes.
Similar content being viewed by others
Introduction
Fear memory traces are formed instantaneously and remain robust throughout an organism’s life span [1, 2], supporting behavioral adaptation under threat. However, fear memories which fail to update their predictive values are no longer efficient and underlie many of the symptomatologies associated with a dysregulated fear response system, such as posttraumatic stress disorder (PTSD). The bed nucleus of stria terminalis (BNST), part of the extended amygdala, has recently gained interest as a site for integration of signals relating to states of anxiety and stress-mediated disorders [3,4,5]. Preclinical models identify synaptic circuits within BNST to process ambiguous threat signals and responses to cue reminders of sustained threat [6, 7], implicating an involvement in long-term fear regulation [8]. Of particular interest is a recent study highlighting neuropeptide Y (NPY), a 36-amino-acid peptide known for its anxiolytic properties [9], as potential mediator of long-term fear regulation within anteroventral BNST (BNSTav) [10]. Pharmacological stimulation of NPY receptor type 2 (Y2R) resulted in a suppression of fear return, whereas blockade of Y2R promoted return of fear at remote stages after extinction training. The presynaptic nature of Y2R [9, 11], the reported influence of NPY on fear regulation in central amygdala (CeA) projecting to anterior BNST [12], and the heterogeneous organization of BNST and neuropeptides present within its nuclei [8, 13], all precluded conclusions regarding the underlying circuits and mechanisms.
Therefore, in the present study, we employed Cre-mediated functional deletion of Y2R in defined subregions of BNST or CeA of Y2lox/lox mice, and combined fear training and behavioral studies in vivo with optogenetic-electrophysiological analysis of BNST synaptic network activity ex vivo, in order to identify regional and cellular underpinnings of Y2R-mediated behavioral effects.
Materials and methods
For detailed description of methods see Supplementary Material and Methods.
Animals
All experiments were carried out in accordance with the European Committees Council Directive (2010/63/EU of the European Parliament) and were approved by the local authority (LANUV). Y2lox/lox mice [14] were used for all experiments. Animals were randomly allocated to the different experimental groups. After surgical procedure, mice were single-housed, maintained on ad libitum diet in a 12 h light–dark cycle.
Stereotaxic surgery and viral infusion
Adult male mice (8–10 weeks) were anesthetized with pentobarbital (50 mg/kg i.p; Narkoren, Pharmacy Universitätsklinikum Münster, Germany), and injected with carprofen (5 mg/kg s.c.; Rimadyl, Pfizer, Berlin, Germany) before stereotaxic surgery (Model 902, David Kopf Instruments, California, USA) [15]. For BNSTav, guide cannulas (26GA, 4 mm, PlasticsOne, Virginia, USA) were implanted bilaterally (AP, +0.4 mm from Bregma; ML, ±2.0 mm from the midline; DV, 4.4 mm at an angle of 14°), and viral injections were performed after 7–10 days of recovery. For BNSTad (AP, +0.4 mm; ML, ±1.8 mm; DV, 3.8 mm) and CeA (AP, −1.6 mm; ML, ±3.1 mm; DV, 3.8 mm), viral injections were performed during the surgical procedure itself. AAV-Syn-ChR2-eYFP (5.6 × 1012 copies/ml) or AAV-Syn-Cre-ChR2-eYFP (1.56 × 1013 copies/ml) were infused bilaterally at a rate of 50 nl/min in a total volume of 150 nl using MicroSyringe pump (UMP3) and controller (Micro4; World Precision Instruments, Sarasota, Florida, USA) connected via 5 µl Hamilton syringe to stainless steel cannulas (33GA, 5 mm). Between 3 and 4 weeks were allowed before commencement of all experiments for adequate transfection of the viral vectors after injections.
Pharmacological procedures
In a subset of animals with BNSTav cannula implantation, the Y2R agonist NPY3–36 (PolyPeptide Laboratories, Strasbourg, France), the Y2R antagonist JNJ-5207787 (Tocris Bioscience, Wiesbaden, Germany), or saline (0.9% NaCl; pH 7.4) were infused bilaterally into BNSTav at a rate of 100 nl/min in a total volume of 300 nl, 20 min prior to extinction training [10, 16]. NPY3–36 and JNJ-5207787 were prepared at the day of the experiment from stock solutions at 200 nM.
While NPY3–36 has a potent affinity for Y2R, it also does have an affinity for Y5R [17]. However, within the BNSTav there is little evidence of functional Y5Rs. This makes NPY3–36 a good agonist for the present study. JNJ-5207787 is a potent and selective Y2R antagonist devoid of affinity for Y1, Y4, and Y5 receptors [18]. Both Y2R ligands have previously been used for in vivo pharmacological experiments in anterior BNST of fear-conditioned mice [10, 16]. Therefore, we chose these ligands to maintain between-study consistency and to replicate the in vivo findings from nongenetically modified mice to the genetically modified Y2Rlox/lox mice.
Verification of injection site and deletion of Y2R
Viral transfection sites were verified by examining the expression of eYFP in 250 μm brain slices comprising the entire BNST. Only animals which showed regional-specific bilateral transfections within BNSTav, BNSTad, or CeA were included for analysis. In pharmacological experiments, position of cannula tips was verified in histological sections. Tissue was prepared as described in [10]. Only animals in which tissue injury was located at or just above BNSTav, were included in analysis. In a subset of animals, BNSTav and BNSTad were laser-dissected (16 μm slices), and specificity of Y2R deletion was verified through PCR assessment of Cre-mediated recombination of Y2R (Supplementary Fig. 1). The expression of Y2R mRNA (16 μm slices) in BNSTav was further quantified using RNAscope (ACDbio, CA, USA; Supplementary Figs. 2 and 3).
Behavioral paradigm
Mice were trained in a differential fear conditioning paradigm as previously described [10] with fear conditioning on day 1 and fear extinction and remote fear recall conducted in a separate context on day 2 and day 16, respectively. Freezing to the CS+ presentations was averaged across three consecutive CS+ presentations (3CS+ block) for extinction training and remote fear recall tests. Freezing scores were analyzed independently by three experienced experimenters.
Ex vivo electrophysiology
On day 17, 24 h after remote fear memory retrieval, mice were decapitated under deep isoflurane anesthesia (2.5% in O2, Abbott, Wiesbaden, Germany) and coronal slices (250 μm) containing the anterior BNST were prepared as previously described [19]. To study the intrinsic connectivity of BNST neurons, channelrhodopsin-2 (ChR2)-assisted “paired” patch-clamp recordings were performed. A ChR2-eYFP-expressing BNST neuron was activated by scanning a somatic region (~3 µm diameter) with a 473 nm laser (~30 ms scan time). Optogenetically activated inhibitory postsynaptic currents (oIPSCs) in neighboring BNST neurons were recorded in whole-cell voltage-clamp mode at a holding potential of 0 mV using a Cs-based internal solution [20]. oIPSC amplitudes were analyzed during baseline, in the presence of the Y2R agonist Peptide YY 3–36 (PYY3–36, Genscript, Piscataway, NJ, USA; bath-applied at 200 nM for 10 min), and after washout. In some experiments, postsynaptic inhibitory currents (eIPSCs) were evoked by a bipolar tungsten stimulation electrode placed dorsally to the recording electrode in the surrounding neuropil. To examine excitation/inhibition (E/I) ratios, individual BNST neurons were first voltage-clamped at −65 mV, and then at 0 mV to record spontaneous excitatory and inhibitory synaptic currents (sEPSCs and sIPSCs), respectively. Electrophysiological data were analyzed offline with Clampfit (Molecular Devices Corporation, Sunnyvale, CA, USA) or Mini Analysis (Synaptosoft Inc., Fort Lee, NJ, USA).
Statistical analysis
Sample size was based on prior studies [7, 10]. All datasets were assessed for outliers using the Grubbs’ test (significance level p < 0.05) or studentized residuals scores (z = ±3). Assumptions for analysis of variance (ANOVA) were tested. In case of sphericity violations, Greenhouse–Geisser corrections were used. Data are presented as mean, mean difference ± standard error of the mean or box and whisker plots (box: 25th to 75th percentiles, whiskers 5th and 95th percentiles), and considered significant at p < 0.05. Statistics were conducted using SPSS (IBM SPSS Statistics, version 24) or GraphPad Prism (GraphPad Software, San Diego, CA). Experiments were performed in a randomized fashion.
In vivo
In statistical analysis of extinction and remote recall, each data point, except the pre-CS, represents a mean of freezing percentages for three consecutive CS+ presentations (3CS+ block). Mixed model two-way ANOVA with freezing percentages as dependent variable and viral injection groups and time as between-subject and within-subject factors, respectively, was used to analyze freezing behavior between groups followed by post hoc Bonferroni for statistically significant interactions. Wilcoxon–Mann–Whitney test was used for statistical analysis of Y2R expression in DAPI-positive cells.
Ex vivo
Statistical significance was tested using either mixed model two-way ANOVA followed by post hoc Sidak’s multiple comparison test, one-way repeated measures ANOVA followed by post hoc Dunnett’s multiple comparison test, or Kruskal–Wallis test followed by post hoc Dunn’s multiple comparison test. Numbers given in text (x/y) refer to numbers of neurons (x) recorded in different animals (y).
Results
Deletion of Y2R in BNSTav increases fear during extinction learning and promotes recall of conditioned and remote fear
In order to investigate the role of local Y2R within the BNSTav, Y2lox/lox mice were bilaterally injected with either AAV-Syn-Cre-ChR2-eYFP (n = 11) for Cre-mediated deletion of Y2R, or with AAV-Syn-ChR2-eYFP (n = 15) as control. Mice were exposed to a differential fear conditioning paradigm [10], and expression of fear was assessed during acquisition (day 1), extinction (day 2) and remote recall of fear (day 16). On the following day, BNST slices were prepared and used for subsequent ex vivo electrophysiological experiments (Fig. 1a). Specificity of transfection sites was histologically verified through eYFP expression in ex vivo slices (Fig. 1b) and through detection of Cre-mediated Y2R recombination via PCR in a subset of animals (n = 6/group; Fig. 1c). Furthermore, expression of Y2R mRNA was detected using RNAScope (Supplementary Fig. 2) and quantified using ImageJ, in control and Cre-injected mice. The percentage of DAPI-positive nuclei coexpressing Y2R mRNA was significantly reduced in Cre-injected mice (p < 0.01) (Supplementary Fig. 3).
To assess for behavioral correlates of Y2R deletion, CS+-evoked freezing levels were statistically compared between the two groups of animals using mixed model ANOVA for repeated measures. All mice acquired fear, and no group differences were found between Cre-injected mice and controls (Fig. 1d). In extinction learning, Cre-injected animals showed a higher level of freezing across time (Fig. 1e). In order to analyze the rate of extinction learning, freezing percentages at each subsequent 3CS+ blocks were statistically compared to the freezing percentage of the first 3CS+ block within each injection group. Significant reduction in freezing occurred by the 3rd 3CS+ block in control and the 4th 3CS+ block in Cre-injected mice, and no differences existed between groups at the last 3CS+ block of extinction training, suggesting that all groups had acquired extinction by the last 3CS+ block (Fig. 1e). Fear recall at remote time point was significantly different between groups, such that the Cre-injected mice displayed higher freezing in response to both the first and the second 3CS+ block, indicating a higher level of remote fear recall as compared to controls (Fig. 1f).
In order to validate the Y2lox/lox mouse model, with respect to pharmacological results obtained with Y2R manipulation in BNST of C57BL/6N mice [10], we injected Y2R agonist (NPY3–36; n = 11), Y2R antagonist (JNJ-5207787; n = 9), and saline (0.9% NaCl; n = 10) bilaterally into BNSTav in a separate group of Y2lox/lox mice (Supplementary Fig. 4). All mice acquired fear and were subsequently divided into three equally performing groups according to freezing levels (Supplementary Fig. 4B). During fear extinction, JNJ-5207787-infused Y2lox/lox mice showed a significantly higher freezing level across time compared to saline-injected animals, whereas NPY3–36-infused animals were not different from controls (Supplementary Fig. 4C). During recall of remote fear, a significant group difference was found depending on time. In JNJ-5207787-infused animals, freezing was higher compared to controls during the first 3CS+ block and remained high during the last 3CS+ block, whereas NPY3–36-infused animals displayed lower freezing compared to controls during the first block of CS+ presentation (Supplementary Fig. 4D).
Deletion of Y2R in BNSTad does not affect acquisition, extinction, or recall of fear
The role of local Y2R within the BNSTad was assessed next by injecting AAV-Syn-Cre-ChR2-eYFP (n = 16) and AAV-Syn-ChR2-eYFP (n = 13) in Y2lox/lox mice. Experimental paradigms (Fig. 2a), verification of transfection specificity (Fig. 2b, c), and behavioral assessment of fear were conducted as for BNSTav. Animals of all groups acquired (Fig. 2d), extinguished (Fig. 2e), and recalled remote fear (Fig. 2f), without differences occurring between groups at any experimental time point during CS+-evoked freezing. Notably, two outliers in the control group displayed baseline freezing at z = 3.23 and z = 3.34 and were included because ANOVA tests with and without the outliers were not statistically different.
No significant differences were found between BNSTad and BNSTav control groups for freezing in fear extinction (compare Figs. 1e and 2e).
Deletion of Y2R in CeA does not affect acquisition, extinction, or remote recall of fear
Finally, we targeted the CeA in Y2lox/lox mice, through bilateral injection of AAV-Syn-Cre-ChR2-eYFP (n = 7) and AAV-Syn-ChR2-eYFP (n = 7), using procedures as described above (Supplementary Fig. 5). No statistically significant difference between groups was observed in fear acquisition, extinction learning, or remote fear recall. Regardless of groups, animals showed similar freezing levels across all behavioral tests.
Y2R activation decreases GABAergic signaling in intraregional BNST microcircuits
In a complementary line of experiments, we investigated the impact of Y2R modulation on BNST microcircuits using ChR2-assisted “paired” patch-clamp recordings in brain slices prepared on the day after remote fear recall. A ChR2-eYFP-expressing BNST neuron was activated by scanning a small circular region of interest (~3 µm diameter) on its soma with a 473 nm laser (~30 ms scan time, Fig. 3a–d, h–k). Focal photoactivation reliably (apparent connectivity ~92%, 59 out of 64 tested pairs) evoked inhibitory postsynaptic currents (oIPSCs) in neighboring neurons recorded at 0 mV in voltage-clamp mode in both BNSTav and BNSTad (Fig. 3e, l). Light-activated postsynaptic currents occurred within laser scan time, were stimulus-locked with little onset latency jitter, and sensitive to GABA receptor antagonists (10 μM Gabazine, 2.5 µM CGP55845; Fig. 3f, m). Bath application of the Y2R agonist PYY3–36 (200 nM) for 10 min significantly reduced oIPSC amplitudes in control mice in both BNSTav and BNSTad neurons (Fig. 3e–g, l–n), indicating a Y2R-mediated modulation of inhibitory intraregional BNST microcircuits. This modulation was lost in Cre-injected mice, corroborating the functional deletion of Y2R in intraregional inhibitory BNST microcircuits (Fig. 3e–g, l–n). These results indicate that PYY3–36 can decrease GABAergic signaling at intraregional BNST synapses via Y2R activation on local BNST interneurons.
Predominantly inter-regional inhibitory BNSTav to BNSTad microcircuits are Y2R-modulated
Next, we tested the impact of Y2R modulation on interregional GABAergic connections between BNSTav and BNSTad using a corresponding experimental approach, but optogenetically activated a neuron in BNSTav and recorded oIPSCs in a BNSTad neuron or vice versa (Fig. 4a, b, e, f). While bath application of 200 nM PYY3–36 for 10 min led to a significant reduction in the mean oIPSC amplitudes of GABAergic inputs from BNSTav to BNSTad neurons (Fig. 4c, d), only a few GABAergic inputs from BNSTad to BNSTav neurons were Y2R-modulated (BNSTav to BNSTad: seven out of eight connected pairs, BNSTad to BNSTav: two out of eight connected pairs, p < 0.05, Fisher’s exact test), and the mean oIPSC amplitude of GABAergic inputs at BNSTad to BNSTav synapses did not change significantly upon PYY3–36 application (Fig. 4g, h). Results indicate that inter-regional inhibitory microcircuits are differentially regulated by local Y2R signaling, with stronger modulatory influence on BNSTav to BNSTad synapses compared to BNSTad to BNSTav synapses.
Extrinsic GABAergic inputs to BNSTad are Y2R-modulated
Next, we tested whether extrinsic axonal inputs to the anterior BNST are regulated via Y2R. Postsynaptic inhibitory currents (eIPSCs) were evoked by a bipolar tungsten stimulation electrode placed dorsally to the recording electrode in the surrounding neuropil in slices from Cre-injected mice, assuming that local Y2R on BNST neurons are deleted (Supplementary Fig. 6A, B, E, F). Bath application of PYY3–36 had no effect on mean eIPSC amplitudes in BNSTav neurons (Supplementary Fig. 6C, D) while most extrinsic GABAergic inputs to BNSTad neurons were modulated by Y2R (BNSTad: 10 out of 13, BNSTav: 0 out of 6, p < 0.01, Fisher’s exact test) and mean eIPSC amplitudes were significantly reduced in BNSTad neurons (Supplementary Fig. 6G, H). These results corroborate specificity of our regional Y2R deletion approach and suggest a prevalent attenuating regulation of extrinsic GABAergic inputs to BNSTad via Y2R.
Local Y2R control excitation/inhibition balance in BNSTav neurons
Considering the differential modulation of distinct intraregional, inter-regional and extraregional GABAergic circuits within the anterior BNST, we tested Y2R influences on network-driven excitation and inhibition balance in the anterior BNST. We recorded sEPSC and sIPSC in individual BNST neurons by voltage-clamping cells first close to the GABA (−65 mV), and then at the glutamate (0 mV) reversal potential (Fig. 4i). To estimate the balance of excitation and inhibition within BNSTav and BNSTad, we calculated E/I ratios (sEPSC frequency/sIPSC frequency, Fig. 4j). Neither sEPSC amplitude and/or frequency nor sIPSC amplitude and/or frequency differed between experimental groups (Fig. 4k–n). However, only deletion of Y2R in BNSTav neurons significantly shifted E/I ratio in BNSTav towards greater inhibitory drive (Fig. 4i, j). These data suggest that endogenous NPY controls E/I balance in BNSTav neurons via local Y2R.
Discussion
Fiber bundles of the stria terminalis and anterior commissure divide the BNST into anterior/posterior and dorsal/ventral sections [21]. The anterior BNST receives massive input from CeA and is well positioned to regulate stress responsiveness owing to its projections to paraventricular hypothalamic nucleus [22] and ventral tegmental area [13]. High levels of Y2R exist in CeA and various subregions of the anterior BNST [23], on both local circuit neurons and within the stria terminalis in association with GABAergic, NPY-negative projection neurons [9]. Here we show that targeting Cre to BNSTav for functional deletion of Y2R in Y2lox/lox mice increases conditioned fear during recall and extinction learning and promotes remote recall of fear, whereas Y2R deletion in BNSTad or CeA has no such effect.
The lack of behavioral effect after Y2R deletion in CeA is in line with observations that BNSTav is sparsely innervated by Y2R-expressing neurons from centromedial amygdala, whereas dense inputs from centrolateral amygdala are devoid of Y2R [13, 24]. Previous findings on Y2R-mediated alteration of fear extinction in CeA [12] are difficult to compare because different training paradigms were used and conclusions relied on both functional deletion of Y2R and overexpression of NPY3–36 in CeA.
Here, deletion of Y2R in BNSTav led to higher freezing in extinction training and remote recall tests, even though no group differences existed in baseline freezing across all behavior, acquisition of fear, or by the end of extinction training. Pharmacological intervention largely mimics these behavioral effects in that a single application of Y2R antagonist in BNSTav increases recall of remote fear and delays extinction learning in both Y2lox/lox (present study) and C57BL/6N mice [10]. Together, these data imply that mediating neurons and Y2R are localized within the BNSTav. Of note, targeting Cre to BNSTav of Y2lox/lox had an additional effect on conditioned fear recall, implying an effect of chronic Y2R deletion on consolidation or retrieval of fear memory. Our conclusions are: (1) Y2R in BNSTav suppresses recall of conditioned and remote fear with a high degree of specificity that cannot merely be attributed to a state-like effect, and (2) local circuit neurons within BNSTav and synaptic targets in the local neuropil are the relevant mediators of these Y2R-mediated behavioral influences.
Locally restricted laser scanning photoactivation via ChR2 combined with targeted whole-cell patch-clamp recordings allowed us to reliably study intrinsic BNST microcircuits. Compared with conventional “bulk” field of view laser stimulation, this approach prevents direct activation of the recorded neuron. Postsynaptic responses occurred stimulus-locked with high fidelity and little onset latency jitter, and they were sensitive to GABAA/B receptor antagonists, corroborating the monosynaptic GABAergic nature of these intrinsic BNST connections. GABAergic neurons account for the majority of the overall BNST population [25,26,27], and inhibitory connections act as a gating mechanism for BNST output and modulation of extrinsic inputs [28,29,30,31,32,33,34]. In keeping with this, functional deletion of Y2R in BNSTav resulted in a decrease in E/I ratio in BNSTav most likely by eliminating a tonically dampening NPY effect on inhibitory drive in intraregional BNSTav microcircuits. Y2R are expressed in local circuit neurons in BNST [9, 23], and activation of presynaptic Y2R reduces GABAergic signaling to BNSTav neurons [35,36,37], although their behavioral significance remained unknown. Our targeted approach revealed that local GABAergic neurons form monosynaptic connections in both BNSTav and BNSTad, and stimulation of presynaptic Y2R attenuates inhibitory signaling at these connections. All tested intraregional connections were Y2R-modulated, arguing against differential cell type specificity. GABAergic neurons in BNSTav and BNSTad are mutually interconnected [13, 32]. Contrary to the homogeneous Y2R modulation of intraregional GABAergic BNST microcircuits, our results indicate that inter-regional inhibitory microcircuits are differentially regulated by local Y2R signaling with stronger modulatory influence on BNSTav to BNSTad synapses compared to BNSTad to BNSTav synapses. Our conclusions are: (1) local GABAergic neurons form monosynaptic connections bearing presynaptic Y2R within and in-between BNSTav and BNSTad, and (2) Y2R stimulation at BNSTav connections is mandatory for Y2R-mediated facilitation of fear extinction and attenuation of remote fear return. Noteworthy BNSTav and BNSTad receive additional strong GABAergic innervation from extrinsic nuclei like CeA [13, 38, 39]. Our results suggest a prevalent attenuating regulation of extrinsic GABAergic inputs to BNSTad via Y2R, which however do not contribute to Y2R-mediated regulation of fear extinction and recovery.
Little experimental evidence exists with regards to the precise source of NPY acting on local BNST Y2Rs. In a series of electrophysiological in vitro studies, Walter and colleagues demonstrated properties of local NPY-positive neurons in the anterior BNST characterized by a persistently high state of excitability [19]. Provided this, it is plausible that these NPY-positive neurons remain readily responsive to behaviorally relevant afferent stimuli ultimately translating into neuronal plasticity during fear extinction and remote fear return. It should be noted too that the highest density of NPY inputs to the BNST originate in the AgRP neurons of the arcuate nucleus of the hypothalamus [40, 41] and any changes in the neuronal activity of these neurons lead to changes in NPY release as well.
Correlation of synaptic network and behavioral function can be derived from activity patterns in optically identified types of neurons in BNSTav, where glutamatergic cells displayed enhanced activity during exposure to an aversive footshock or conditioned cue whereas GABAergic cells were inhibited [42], likely resulting in a marked increase in E/I ratio. Furthermore, chronic restraint stress increases NPY expression in BNST in DBA/2J mice [37, 43], and intranasal administration of NPY prior to or after stress exposure can attenuate or reverse PTSD-like behavior in rats, respectively [44, 45]. In human patients with PTSD, NPY plasma levels loosely parallel the disease course [9], implicating that NPY can act as a stress buffer in response to traumatic events in both rodents [46] and humans [47]. One study of a human single nucleotide polymorphism (SNP) which affects the expression of Y2Rs points to a correlation of increased Y2R expression to a decay in iconic memory processes [48]. Further studies are required however to draw a specific link between the Y2R gene polymorphisms in humans and their role in fear-related memory. Our study extends these conclusions by noting that extinction training after threat exposure is a relevant stimulus for recruitment of the NPY-Y2R system in BNSTav, where stimulation of Y2R on GABAergic interneurons regulates the E/I balance in local microcircuits (Fig. 5). The behavioral correlate is evident as facilitated extinction of a learned response to a threat and attenuation of its return at remote stages. Such a mechanism seems well suited to improve resilience against persistence of a threat response and symptomatologies associated with a dysregulated fear response system, such as PTSD.
References
Maren S. Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci. 2001;24:897–931.
Gale GD, Anagnostaras SG, Godsil BP, Mitchell S, Nozawa T, Sage JR, et al. Role of the basolateral amygdala in the storage of fear memories across the adult lifetime of rats. J Neurosci. 2004;24:3810–5.
Tovote P, Fadok JP, Luthi A. Neuronal circuits for fear and anxiety. Nat Rev Neurosci. 2015;16:317–31.
Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol. 2003;463:199–216.
Lebow MA, Chen A. Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry. 2016;21:450–63.
Goode TD. Role of the bed nucleus of the stria terminalis in aversive learning and memory. Learn Mem. 2017;24. https://doi.org/10.1101/lm.044206.116.
Lange MD, Daldrup T, Remmers F, Szkudlarek HJ, Lesting J, Guggenhuber S, et al. Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat. Mol Psychiatry. 2016;22:1422–30.
Miles OW, Maren S. Role of the bed nucleus of the stria terminalis in PTSD: insights from preclinical models. Front Behav Neurosci. 2019;13:68.
Tasan RO, Verma D, Wood J, Lach G, Hormer B, de Lima TCM, et al. The role of Neuropeptide Y in fear conditioning and extinction. Neuropeptides. 2015;55:111–26.
Verma D, Tasan R, Sperk G, Pape H-C. Neuropeptide Y2 receptors in anteroventral BNST control remote fear memory depending on extinction training. Neurobiol Learn Mem. 2018;149:144–53.
Reichmann F, Holzer P. Neuropeptide Y: a stressful review. Neuropeptides. 2016;55. https://doi.org/10.1016/j.npep.2015.09.008.
Verma D, Wood J, Lach G, Mietzsch M, Weger S, Heilbronn R, et al. NPY Y2 receptors in the central amygdala reduce cued but not contextual fear. Neuropharmacology. 2015;99:665–74.
Gungor NZ, Pare D. Functional heterogeneity in the bed nucleus of the stria terminalis. J Neurosci. 2016;36:8038–49.
Sainsbury A, Schwarzer C, Couzens M, Fetissov S, Furtinger S, Jenkins A, et al. Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci USA. 2002;99:8938–43.
Franklin K, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 3rd edn. Academic Press/Elsevier: New York, 2008.
Verma D, Jamil S, Tasan RO, Lange MD, Pape H-C. Single stimulation of Y2 receptors in BNSTav facilitates extinction and dampens reinstatement of fear. Psychopharmacology. 2018;236:281–91.
Mittapalli GK, Roberts E. Ligands of the neuropeptide Y Y2 receptor. Bioorg Med Chem Lett. 2013;24:430–41.
Bonaventure P, Nepomuceno D, Mazur C, Lord B, Rudolph DA, Jablonowski JA. et al. Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptor. J Pharmacol Exp Ther. 2003;308:1130–7.
Walter AL, Bartsch JC, Datunashvili M, Blaesse P, Lange MD, Pape H-C. Physiological profile of neuropeptide Y-expressing neurons in bed nucleus of stria terminalis in mice: state of high excitability. Front Cell Neurosci. 2018;12:393.
Hübner C, Bosch D, Gall A, Luthi A, Ehrlich I. Ex vivo dissection of optogenetically activated mPFC and hippocampal inputs to neurons in the basolateral amygdala: implications for fear and emotional memory. Front Behav Neurosci. 2014;8:64.
Hammack SE, Mania I, Rainnie DG. Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J Neurophysiol. 2007;98:638–56.
Herman JP, Ostrander MM, Mueller NK, Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:1201–13.
Tasan RO, Nguyen NK, Weger S, Sartori SB, Singewald N, Heilbronn R, et al. The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci. 2010;30:6282–90.
Wood J, Verma D, Lach G, Bonaventure P, Herzog H, Sperk G, et al. Structure and function of the amygdaloid NPY system: NPY Y2 receptors regulate excitatory and inhibitory synaptic transmission in the centromedial amygdala. Brain Struct Funct. 2015;221:3373–91.
Daniel SE, Rainnie DG. Stress modulation of opposing circuits in the bed nucleus of the stria terminalis. Neuropsychopharmacology. 2015;41:103.
Larriva-Sahd J. Histological and cytological study of the bed nuclei of the stria terminalis in adult rat. II. Oval nucleus: extrinsic inputs, cell types, neuropil, and neuronal modules. J Comp Neurol. 2006;497:772–807.
Nguyen AQ, Sun Y, Holmes TC, Xu X. Genetic cell targeting uncovers specific neuronal types and distinct subregions in the bed nucleus of the stria terminalis. J Comp Neurol. 2016;524:2379–99.
Dong H-W, Swanson LW. Projections from bed nuclei of the stria terminalis, dorsomedial nucleus: implications for cerebral hemisphere integration of neuroendocrine, autonomic, and drinking responses. J Comp Neurol. 2005;494:75–107.
Dong H-W, Swanson LW. Projections from bed nuclei of the stria terminalis, anteromedial area: cerebral hemisphere integration of neuroendocrine, autonomic, and behavioral aspects of energy balance. J Comp Neurol. 2005;494:142–78.
Dong H-W, Swanson LW. Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis. J Comp Neurol. 2003;468:277–98.
Xu X, Ikrar T, Sun Y, Santos R, Holmes TC, Francesconi W, et al. High-resolution and cell-type-specific photostimulation mapping shows weak excitatory vs. strong inhibitory inputs in the bed nucleus of the stria terminalis. J Neurophysiol. 2016;115:3204–16.
Turesson HK, Rodríguez-Sierra OE, Pare D. Intrinsic connections in the anterior part of the bed nucleus of the stria terminalis. J Neurophysiol. 2013;109:2438–50.
Dong H-W, Swanson LW. Projections from bed nuclei of the stria terminalis, magnocellular nucleus: implications for cerebral hemisphere regulation of micturition, defecation, and penile erection. J Comp Neurol. 2005;494:108–41.
Dong H-W, Swanson LW. Projections from the rhomboid nucleus of the bed nuclei of the stria terminalis: implications for cerebral hemisphere regulation of ingestive behaviors. J Comp Neurol. 2003;463:434–72.
McCall NM, Sprow GM, Delpire E, Thiele TE, Kash TL, Pleil KE. Effects of sex and deletion of neuropeptide Y2 receptors from GABAergic neurons on affective and alcohol drinking behaviors in mice. Front Integr Neurosci. 2013;7:100.
Kash TL, Winder DG. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology. 2006;51:1013–22.
Pleil KE, Lopez A, McCall N, Jijon AM, Bravo JP, Kash TL. Chronic stress alters neuropeptide y signaling in the bed nucleus of the stria terminalis in DBA/2J but not C57BL/6J mice. Neuropharmacology. 2012;62:1777–86.
Sun N, Cassell MD. Intrinsic GABAergic neurons in the rat central extended amygdala. J Comp Neurol. 1993;330:381–404.
Li C, Pleil KE, Stamatakis AM, Busan S, Vong L, Lowell BB, et al. Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling. Biol Psychiatry. 2012;71:725–32.
Betley JN, Cao ZFH, Ritola KD, Sternson SM. Parallel, redundant circuit organization for homeostatic control of feeding behavior. Cell. 2013;155:1337–50.
Nilsson I, Johansen JE, Schalling M, Hokfelt T, Fetissov SO. Maturation of the hypothalamic arcuate agouti-related protein system during postnatal development in the mouse. Brain Res Dev Brain Res. 2005;155:147–54.
Kim S-Y, Adhikari A, Lee SY, Marshel JH, Kim CK, Mallory CS, et al. Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature. 2013;496:219–23.
Pleil KE, Rinker JA, Lowery-Gionta EG, Mazzone CM, McCall NM, Kendra AM, et al. NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking. Nat Neurosci. 2015;18:545–52.
Serova LI, Tillinger A, Alaluf LG, Laukova M, Keegan K, Sabban EL. Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats. Neuroscience. 2013;236:298–312.
Serova LI, Laukova M, Alaluf LG, Pucillo L, Sabban EL. Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model. Eur Neuropsychopharmacol. 2013;24:142–7.
Cohen H, Liu T, Kozlovsky N, Kaplan Z, Zohar J, Math’e AA. The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology. 2011;37:350–63.
Wu G, Feder A, Cohen H, Kim JJ, Calderon S, Charney DS. Understanding resilience. Front Behav Neurosci. 2013;7:10.
Hörmer BA, Verma D, Gasser E, Wieselthaler-Hölzl A, Herzog H, Tasan RO. Hippocampal NPY Y2 receptors modulate memory depending on emotional valence and time. Neuropharmacology. 2018;143:20–8.
Acknowledgements
We thank Peter Blaesse and Kay Jüngling for helpful discussion, Beat Lutz (University Medical Center of the Johannes Gutenberg University Mainz, Germany) for providing the AAV-Cre vector, and Herbert Herzog (Garvan Institut of Medical Research, Darlinghurst, Australia) for providing Y2lox/lox mice for breeding. Thanks are due to Katrin Foraita, Alexandra Markovic, Petra Berenbrock, and Hubert Bäumer for excellent technical assistance and animal care.
Funding
This work was funded by the Sonderforschungsbereich SFB-TRR58 (A03, to H-CP). Open access funding provided by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
The first two authors (JCB, SJ) contributed equally to this paper and appear in alphabetical order. The last two authors (DV, H-CP) contributed equally to this paper. JCB, DV, and H-CP conceptualized the study. SJ and DV conducted and analyzed the behavioral experiments, with contribution by JR. JCB conducted and analyzed the ex vivo experiments. JCB, SJ, DV, and H-CP wrote the paper. All authors commented and agreed on the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bartsch, J.C., Jamil, S., Remmes, J. et al. Functional deletion of neuropeptide Y receptors type 2 in local synaptic networks of anteroventral BNST facilitates recall and increases return of fear. Mol Psychiatry 26, 2900–2911 (2021). https://doi.org/10.1038/s41380-020-0846-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-020-0846-x